Prostate cancer is one of the most common cancers in men but often goes unnoticed. Experts stress early screening, awareness ...

Here’s what you need to do before you go to the doctor. Be sure to call your insurance before your appointment and ask if they’ll help cover a facility fee. Bottom line: if you go to one of these ...

A prominent doctor has tackled several frequently asked questions regarding prostate cancer in a bid to distinguish fact from ...

Dr Thornton stressed that ignoring symptoms and postponing doctor visits are among the worst strategies for dealing with ...

Soldiers serving in the U.S. Army will get daily mental health checks to ensure they’re holding up well over the holiday season. A letter sent to troops from Army Secretary Dan Driscoll this week said ...

Men diagnosed with prostate cancer have traditionally faced two choices: Do nothing and hope the tumor doesn’t grow between scans or start aggressive treatment. Those with certain types of medium-risk ...

La Toya Jackson, sister of icons Michael Jackson and Janet Jackson, has shared a cryptic health update. The entertainer posted two videos in the span of one week, reportedly from a doctor's office. La ...

DEAR DR. ROACH: I am a 68-year old male in good health who exercises regularly, doesn’t take any medications, and doesn’t have a family history of prostate cancer. During my most recent yearly ...

The 69-year-old singer kept a positive tone in her message to fans while prompting an outpouring of concern and support online. La Toya Jackson’s latest social media post has fans worried after the ...

It’s not always an easy conversation for men to have, but talking about prostate problems is a critical part of staying healthy. Symptoms such as urinary frequency, urgency, or difficulty going to the ...

COLUMBIA, S.C. — Prostate cancer is the second leading cause of cancer deaths in men, according to the South Carolina Department of Public Health. Now, a special legislative committee is exploring ...

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay disease progression in men with specific DNA repair gene mutations. In the ...